# RISK: __Lack of access to pharmaceutical interventions__ (PBN__Risk_1158)

## Property: has_RiskGBN

* [No](PBN__RiskGBN_0)

## Property: has_RiskName

Higher morbidity and mortality rates in affected populations

## Property: has_RiskDescription

Developing countries may not have timely access to antiviral medicines and vaccines

## Property: has_RiskTechnology

* [nan](PBN__Technology_22)

## Property: has_RiskType

* [technological](PBN__RiskType_5)

## Property: has_RiskSubject

* [developing countries](PBN__Stakeholder_223)

## Property: has_RiskMitigation

* [Focus on non-pharmaceutical interventions, prioritize distribution to countries in need](PBN__RiskMitigation_1610)

## Property: has_RiskSource

* [bauerle_e-mental_2020](PBN__Article_209)

## Property: has_RiskOwner

* [governments](PBN__Stakeholder_47)
* [international organizations](PBN__Stakeholder_242)
* [pharmaceutical companies](PBN__Stakeholder_124)

## Property: has_RiskISO_Impact

* [Biodiversity and ecosystem services](PBN__RiskISO_Purpose_4)

## Property: has_RiskISO_Purpose

* [Attractiveness](PBN__RiskISO_Impact_9)

## Property: has_RiskHealth

* [physical](PBN__RiskHealth_0)

